Medical Economics March 6, 2024
Critics air concerns at White House roundtable as pharmacy benefit manager volley back.
Wrangling over prescription drug prices continues in Washington.
On March 4, President Joe Biden convened a “White House Roundtable on Lowering Healthcare Costs and Bringing Transparency to Prescription Drug Middlemen,” a meeting with policy advisers and experts on high costs of pharmaceuticals.
The White House’s official summary said guests included Kentucky Gov. Andy Beshear, who explained efforts to save that state up to $300 million in pharmaceutical expenses.
Sandra Clarke, chief operating officer of Blue Shield of California, called for more transparency in pricing and said some dominant middlemen block lower-priced generic drugs and biosimilars from getting to patients.
Cost-Plus Drugs founders Mark Cuban and Dr. Alex...
Today's Sponsors
Today's Sponsor